Page last updated: 2024-08-25

doqualast and Breast Neoplasms

doqualast has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balwierz, A; Hielscher, T; Küblbeck, M; Pawitan, Y; Sahin, Ö; Ward, A; Wiemann, S; Zhang, JD	1

Other Studies

1 other study(ies) available for doqualast and Breast Neoplasms

Article	Year
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene, 2013, Feb-28, Volume: 32, Issue:9 Topics: Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Disease-Free Survival; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; MicroRNAs; Neoplasm Invasiveness; Quinazolines; RNA-Binding Proteins; Tamoxifen	2013

Article

Year

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer.

Oncogene, 2013, Feb-28, Volume: 32, Issue:9

Topics: Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Disease-Free Survival; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; MicroRNAs; Neoplasm Invasiveness; Quinazolines; RNA-Binding Proteins; Tamoxifen

2013